HDACs are implicated in cancer partly through their silencing of tumour suppressor genes, e.g., the hypoacetylation status of the p21WAF1 promoter and its corresponding gene inactivation can be reversed by HDAC inhibitors via histone hyperacetylation of in the promoter [50]. The gene discussed is HDAC9; the disease is neoplasm.